Cargando…
Correction: The induction of core pluripotency master regulators in cancers defines poor clinical outcomes and treatment resistance
Autores principales: | Hepburn, A. C., Steele, R. E., Veeratterapillay, R., Wilson, L., Kounatidou, E. E., Barnard, A., Berry, P., Cassidy, J. R., Moad, M., El-Sherif, A., Gaughan, L., Mills, I. G., Robson, C. N., Heer, R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7608372/ https://www.ncbi.nlm.nih.gov/pubmed/31068666 http://dx.doi.org/10.1038/s41388-019-0826-2 |
Ejemplares similares
-
The induction of core pluripotency master regulators in cancers defines poor clinical outcomes and treatment resistance
por: Hepburn, A. C., et al.
Publicado: (2019) -
Propagation of human prostate tissue from induced pluripotent stem cells
por: Hepburn, Anastasia C., et al.
Publicado: (2020) -
A novel CRISPR-engineered prostate cancer cell line defines the AR-V transcriptome and identifies PARP inhibitor sensitivities
por: Kounatidou, Evangelia, et al.
Publicado: (2019) -
Side Population in Human Non-Muscle Invasive Bladder Cancer Enriches for Cancer Stem Cells That Are Maintained by MAPK Signalling
por: Hepburn, Anastasia C., et al.
Publicado: (2012) -
Identification of CNGB1 as a Predictor of Response to Neoadjuvant Chemotherapy in Muscle-Invasive Bladder Cancer
por: Hepburn, Anastasia C., et al.
Publicado: (2021)